Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

90 trials

NCT05568680
Recruiting
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
Phase 1 · United States · 5 sites
Registry update: 24 Jun 2026
NCT05765084
Recruiting
Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma
Phase 1/2 · Belgium · 3 sites
Registry update: 5 Jun 2026
NCT03760575
Recruiting
Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)
Phase 1 · United States · 1 site
Registry update: 4 Dec 2025
NCT05579366
Recruiting
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Phase 1/2 · China, Japan, South Korea, United States · 67 sites
Registry update: 4 Nov 2026
NCT05245500
Recruiting
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Phase 1 · United States · 24 sites
Registry update: 2 Sept 2026
NCT04400539
Recruiting
The IMmunotherapy Pleural 5-ALA PDT
Phase 2 · France · 1 site
Registry update: 25 Sept 2025
NCT05001880
Recruiting
Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
Phase 2 · United States · 41 sites
Registry update: 26 Oct 2026
NCT05627960
Recruiting
First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies
Phase 1 · United States · 1 site
Registry update: 28 Nov 2022
NCT04996017
Recruiting
Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso)
Phase 3 · Italy · 19 sites
Registry update: 13 Mar 2025
NCT05304208
Recruiting
dENdritic Cell Therapy Combined With SURgEry in Mesothelioma
Phase 1 · Netherlands · 1 site
Registry update: 29 Sept 2026
NCT04981119
Recruiting
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Not applicable · United States · 16 sites
Registry update: 26 Oct 2026
NCT04847063
Recruiting
Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
Phase 1 · United States · 1 site
Registry update: 9 Nov 2026
NCT05107674
Recruiting
A Study of NX-1607 in Adults With Advanced Malignancies
Phase 1 · United Kingdom, United States · 17 sites
Registry update: 9 Sept 2025
NCT04024917
Recruiting
Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis
Not applicable · France · 1 site
Registry update: 16 Jan 2026
NCT04431024
Recruiting
Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome
Not applicable · United States · 1 site
Registry update: 29 Oct 2026
NCT04665206
Recruiting
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
Phase 1/2 · Australia, United States · 12 sites
Registry update: 2 Apr 2026
NCT04515836
Recruiting
Olaparib in Patients With HRD Malignant Mesothelioma
Phase 2 · United States · 1 site
Registry update: 6 May 2025
NCT04115254
Recruiting
Stereotactic Magnetic Resonance Guided Radiation Therapy
Not applicable · United States · 2 sites
Registry update: 13 Nov 2025
NCT04104776
Recruiting
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Phase 1/2 · Spain, France, United Kingdom, Italy, South Korea, Poland, United States · 76 sites
Registry update: 19 Aug 2026
NCT03917043
Recruiting
APG-2449 in Patients With Advanced Solid Tumors
Phase 1 · China · 9 sites
Registry update: 23 Jul 2026

Ordered by registry start date. Freshness and sponsorship never change the order.